Ionis Pharmaceuticals Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 121.60M-13.23M99.09M102.05M-19.36M214.16M283.70M372.78M514.18M35.00M35.00M729.26M60.00M587.37M787.65M705.14M
Cost of Revenue 1.82M4.38M11.95M10.84M14.12M9.13M11.21M
Gross Profit 121.60M-13.23M99.09M102.05M-19.36M214.16M283.70M372.78M514.18M33.18M30.62M717.32M49.16M573.25M778.51M693.92M
Operating items
Research & Development 134.62M145.16M157.40M158.46M184.03M241.75M322.29M344.32M374.64M414.60M465.69M535.08M643.45M833.15M899.62M901.53M
Selling, General & Administrative 14.52M11.67M12.79M12.52M14.92M20.14M37.17M48.62M108.49M244.62M286.64M354.32M186.35M150.29M232.62M267.47M
Other Operating Expenses 1.82M4.38M11.95M10.84M149.60M-0.16M-0.01M
Operating Expenses 149.14M156.83M170.19M170.97M198.95M261.89M359.46M392.94M483.13M661.05M756.72M901.35M840.64M997.56M1141.38M1180.22M
Operating Income -27.54M-48.36M-71.10M-68.92M-51.67M-47.73M-75.76M-20.16M31.05M-61.37M365.88M-172.08M-30.19M-410.19M-353.73M-475.08M
EBIT -27.54M-48.36M-71.10M-68.92M-51.67M-47.73M-75.76M-20.16M31.05M-61.37M365.88M-172.08M-30.19M-410.19M-353.73M-475.08M
Non-operating items
Non Operating Investment Income 2.08M4.65M4.18M18.36M2.38M19.90M-0.21M0.19M16.54M10.10M-7.33M-1.91M-2.89M
Interest & Investment Income 6.36M3.37M2.41M1.84M2.08M2.68M4.38M5.47M8.18M30.40M52.01M30.56M10.04M25.33M89.04M107.02M
Other Non Operating Income -4.77M-8.29M-3.98M-3.55M-0.18M-66.20M-0.06M-9.76M-7.27M14.26M1.34M
Non Operating Income 4.30M1.74M-0.69M-0.06M-9.76M-7.27M14.26M1.34M
Net income details
EBT -31.77M-61.16M-84.79M-74.59M-66.56M-54.39M-87.91M-57.47M-16.76M-76.16M338.77M-137.22M-29.97M-258.49M-334.71M-460.71M
Tax Provisions 3.19M0.09M0.01M-9.11M-5.91M-15.41M0.37M2.93M-5.98M-291.14M51.51M345.19M-0.55M11.74M32.32M-6.17M
Profit After Tax 150.67M-61.25M-84.80M-65.48M-60.64M-38.98M-88.28M-60.40M-10.78M273.74M287.26M-479.74M-28.60M-269.72M-366.29M-453.90M
Equity Income -6.88M-3.55M-1.41M
Income from Non-Controlling Interests -4.39M-11.13M-58.76M9.12M-35.48M
Income from Continuing Operations -34.96M-61.25M-84.80M-65.48M-60.64M-38.98M-88.28M-60.40M-10.78M214.99M287.26M-482.41M-29.41M-270.23M-367.03M-454.54M
Consolidated Net Income 185.66M-61.25M-84.80M-65.48M-60.64M-38.98M-88.28M-60.40M-10.78M214.99M287.26M-482.41M-29.41M-270.23M-367.03M-454.54M
Income towards Parent Company 185.66M-61.25M-84.80M-65.48M-60.64M-38.98M-88.28M-60.40M-10.78M214.99M287.26M-482.41M-29.41M-270.23M-367.03M-454.54M
Net Income towards Common Stockholders 155.07M-61.25M-84.80M-65.48M-60.64M-38.98M-88.28M-60.40M-10.78M214.99M287.26M-482.41M-29.41M-270.23M-367.03M-454.54M
Additional items
EPS (Basic) 0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) 0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 98.38M99.23M99.73M101.21M116.07M118.14M120.66M121.20M124.80M137.57M140.66M139.82M141.21M142.05M143.47M157.90M
Shares Outstanding (Diluted Average) 98.11M99.14M99.66M100.58M110.50M141.02M141.85M143.19M149.51M
EBITDA -27.54M-48.36M-71.10M-68.92M-51.67M-47.73M-75.76M-20.16M31.05M-61.37M365.88M-172.08M-30.19M-410.19M-353.73M-475.08M
Tax Rate 12.21%8.89%28.33%35.67%15.20%1.84%1.34%